Stock DNA
Chemicals & Petrochemicals
CNY 1,056 Million (Micro Cap)
NA
0.00%
0.21
-999,999.00%
0.30
Revenue and Profits:
Net Sales:
1,477 Million
(Quarterly Results - Sep 2025)
Net Profit:
234 Million
Total Returns (Price + Dividend) 
Company does not have enough history
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
6.40%
EBIT Growth (5y)
-16.07%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
67.68%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
EV to EBIT
EV to EBITDA
EV to Capital Employed
EV to Sales
PEG Ratio
NA
Dividend Yield
ROCE (Latest)
ROE (Latest)
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
RSI
No Signal
Bollinger Bands
Bearish
Moving Averages
Bearish (Daily)
KST
Bullish
Dow Theory
Bearish
Bearish
OBV
Mildly Bullish
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
4,235.50
3,868.30
9.49%
Operating Profit (PBDIT) excl Other Income
598.00
639.60
-6.50%
Interest
69.80
65.00
7.38%
Exceptional Items
-3.10
-0.10
-3,000.00%
Consolidate Net Profit
290.80
337.80
-13.91%
Operating Profit Margin (Excl OI)
84.20%
107.80%
-2.36%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 9.49% vs -24.14% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -13.91% vs -48.94% in Dec 2023






